e13576 Background: Cancer-related malnutrition affects treatment tolerance this study evaluates nutritional status, predictors of malnutrition p < 0.001). Compared to breast cancer, higher malnutrition risk was observed in head & neck (OR 4.2, 95%CI 2.9-6.1),gastrointestinal (OR 3.1, 95%CI 2.1-4.6), lung (OR 4.0, 95% CI 2.3-7.0) & gynecological cancers (OR 1.98, 95% CI 1.4-2.9) (p < 0.001). Improvement rates in malnourished varied by cancer type, with lower improvement observed in head & neck cancer (42.5%) compared with gastrointestinal (69.5%), breast (63.5%), gynecological (61.5%) & lung cancer (55%). Improvements were noted across nutritional domains: disease-related requirements (34.0%), muscle mass (34.4%), fat stores (33.3%), weight loss (32.1%), functional status (29.5%), dietary intake (28.7%) & GI symptoms (20.1%).Median overall survival (mOS) was 84.9 mo at baseline in severe/mild/moderate malnourished patients while mOS was not reached in well-nourished patients (p < 0.001). Conclusions: In this study, SGA effectively identified malnutrition, revealed tumor-specific risk patterns & correlated with survival outcomes underscoring its value as a practical & prognostically informative tool in routine oncology care.
Kalaskar et al. (Thu,) studied this question.